1,2,3,4-tetrahydroquinoline has been researched along with Charcot-Marie-Tooth Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bařinka, C; Benoy, V; Kozikowski, AP; Kutil, Z; Langley, B; Pavlíček, J; Picci, C; Robers, MB; Shen, S; Tavares, MT; Ustinova, K; Van Den Bosch, L; Zhang, G; Zimprich, CA | 1 |
1 other study(ies) available for 1,2,3,4-tetrahydroquinoline and Charcot-Marie-Tooth Disease
Article | Year |
---|---|
Tetrahydroquinoline-Capped Histone Deacetylase 6 Inhibitor SW-101 Ameliorates Pathological Phenotypes in a Charcot-Marie-Tooth Type 2A Mouse Model.
Topics: Acetylation; Animals; Benzamides; Binding Sites; Charcot-Marie-Tooth Disease; Crystallography, X-Ray; Disease Models, Animal; Half-Life; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Humans; Male; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Phenotype; Protein Isoforms; Quinolines; Structure-Activity Relationship; Tubulin | 2021 |